SCHEMBL5852341

SCHEMBL5852341

COC(=O)[C@H](Cc1ccc(NC(=O)C2CCN(C(=O)OC(C)(C)C)CC2)cc1)NC(=O)C(C)(C)N(C)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.48
PTPN1 P18031 1/20 0.48
PTPN6 P29350 1/20 0.48
YAP1 P46937 1/20 0.44
TRPV1 Q8NER1 1/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
ABL1 P00519 1/20 0.44
RIN1 Q13671 1/20 0.44
P2RX7 Q99572 2/20 0.43
STS P08842 3/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42
MMP13 P45452 1/20 0.41
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
EPHX2 P34913 1/20 0.40
PABPC1 P11940 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5850632 0.87 ALDH1A1 (0.41) TRPV1KMT2AMEN1ALDH1A1LMNA
SCHEMBL5850463 0.86 PTPN2 (0.46) PTPN2PTPN1PTPN6YAP1TRPV1
SCHEMBL5690604 0.78 ENPP2 (0.48) YAP1P2RX7NPC1RAB9AALDH1A1
SCHEMBL7970301 0.76 PTPN2 (0.44) PTPN2PTPN1PTPN6TRPV1KMT2A
SCHEMBL5690885 0.76 ITGB1 (0.58) PTPN2PTPN1PTPN6ALDH1A1
SCHEMBL5690682 0.74 HCRTR1 (0.51) YAP1NPC1RAB9AALDH1A1MAPT
SCHEMBL5690922 0.74 PTPN2 (0.43) PTPN2PTPN1PTPN6TRPV1KMT2A
SCHEMBL5690337 0.73 ENPP2 (0.49) YAP1KMT2AP2RX7NPC1RAB9A
SCHEMBL5692100 0.73 PTPN2 (0.44) PTPN2PTPN1PTPN6TRPV1KMT2A
SCHEMBL5690698 0.73 MAPK1 (0.53) KMT2AMEN1NPC1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994895-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-04-26 EP claimed
WO-1999006435-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-7030114-B1 Compounds which inhibit leukocyte adhesion mediated by VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2006-04-18 US disclosed
EP-0994895-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-04-26 EP disclosed
WO-1999006435-A1 DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed